The programme committee consists of a diverse group of experts from academia, industry, and governmental bodies working in the field of drug development and Antimicrobial Resistance (AMR). This combination of profiles and expertise ensures a broad range of perspectives when addressing the development of new antimicrobials and the challenges posed by AMR in the use of existing agents.
